{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02645305",
      "OrgStudyIdInfo": {
        "OrgStudyId": "2555/QD-BYT"
      },
      "Organization": {
        "OrgFullName": "University of Science Ho Chi Minh City",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease",
      "OfficialTitle": "Evaluation of Safety and Efficacy of Autologous Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease"
    },
    "StatusModule": {
      "StatusVerifiedDate": "December 2015",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "June 2015"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 2016",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2016",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "December 21, 2015",
      "StudyFirstSubmitQCDate": "December 30, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 1, 2016",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "December 30, 2015",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 1, 2016",
        "LastUpdatePostDateType": "Estimate"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Phuc Van Pham",
        "ResponsiblePartyInvestigatorTitle": "MSc, PhD.",
        "ResponsiblePartyInvestigatorAffiliation": "University of Science Ho Chi Minh City"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Science Ho Chi Minh City",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Van Hanh General Hospital",
            "CollaboratorClass": "OTHER"
          },
          {
            "CollaboratorName": "Nguyen Tri Phuong Hospital, Ho Chi Minh city, Viet Nam",
            "CollaboratorClass": "UNKNOWN"
          },
          {
            "CollaboratorName": "GeneWorld Ltd Co, Ho Chi Minh city, Viet Nam",
            "CollaboratorClass": "UNKNOWN"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Chronic obstructive pulmonary disease (COPD) is the name for a collection of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways disease. People with COPD have difficulties breathing, primarily due to the narrowing of their airways, this is called airflow obstruction.\n\nSome preclinical evaluations showed that COPD is closely related to chronic inflammation; therefore, this study aimed to use adipose-derived stem cells (ADSCs) in the form of non-expanded culture - that usually names as a stromal vascular fraction (SVF) in combination with activated platelet rich plasma (PRP) to treat this disease. Both SVF and PRP are autologous sources that obtained from adipose tissue and peripheral blood, respectively. This mixture is intravenously transfused into the patients."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "COPD"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Safety and Efficacy",
          "Adipose stem cells",
          "Stem Cell therapy"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "20",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Treatment",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Autologous stromal vascular fraction (SVF) and platelet rich plasma (PRP) will be transfused into 20 COPD patients.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Adipose derived stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Adipose derived stem cells",
            "InterventionDescription": "Adipose derived stem cells that are isolated from adipose tissue are mesenchymal stem cells with high immune modulation capacity. Therefore, they can effectively modulate the immune system.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Treatment"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Adipose derived stem cells and platelet rich plasma",
                "ADSC and PRP"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "SGOT",
            "PrimaryOutcomeDescription": "The blood SGOT levels are thus elevated with liver damage",
            "PrimaryOutcomeTimeFrame": "1 month"
          },
          {
            "PrimaryOutcomeMeasure": "SGPT",
            "PrimaryOutcomeDescription": "The blood SGPT levels are thus elevated with liver damage",
            "PrimaryOutcomeTimeFrame": "1 month"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Respiration rate",
            "SecondaryOutcomeTimeFrame": "1 month, 6 months, 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "6 min walk test",
            "SecondaryOutcomeTimeFrame": "1 month, 6 months, 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "rates of panic attacks",
            "SecondaryOutcomeTimeFrame": "1 month, 6 months, 12 months"
          },
          {
            "SecondaryOutcomeMeasure": "CRP concentration",
            "SecondaryOutcomeDescription": "The CRP concentration in the patients were evaluated before and after treatment for 6 and 12 months",
            "SecondaryOutcomeTimeFrame": "6 months, 12 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nAge 40 to 80, inclusive\nA prior diagnosis of moderate to severe COPD\nGOLD IIa, III, IV\n\nExclusion Criteria:\n\nPregnant or lactating\nLife expectancy < 6 months due to concomitant illnesses.\nExposure to any investigational drug or procedure within 1 month prior to study entry or enrolled in a concurrent study that may confound results of this study.\nAny illness which, in the Investigators judgment, will interfere with the patient's ability to comply with the protocol, compromise patient safety, or interfere with the interpretation of study results\nSubjects on chronic immunosuppressive or chemotherapeutic therapy\nKnown drug or alcohol dependence or any other factors which will interfere with the study conduct or interpretation of the results or who in the opinion of the investigator are not suitable to participate.\nSubjects with Alpha-1 antitrypsin deficiency (an inherited disorder that can cause lung disease and liver disease).\nUnwilling and/or not able to give written consent\nPatient is positive for hepatitis (past history of Hepatitis A is allowed)\nAny medical condition, which in the opinion of the clinical investigator, would interfere with the treatment or outcome of the patient\nCerebral aneurysm clips",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "40 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Van Hanh Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Ho Chi Minh City",
            "LocationCountry": "Vietnam",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Phuong Le Thi Bich, MSc., MD",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "drbichphuong@gmail.com"
                },
                {
                  "LocationContactName": "Phuong Le Thi Bich, MSc., MD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Chien Vo Duc, MD.",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University, Ho Chi Minh",
            "LocationStatus": "Recruiting",
            "LocationCity": "Ho Chi Minh",
            "LocationCountry": "Vietnam",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Phuc V Pham, PhD",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+84903870153",
                  "LocationContactEMail": "pvphuc@hcmuns.edu.vn"
                },
                {
                  "LocationContactName": "Phuc V Pham, PhD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Nguyen Tri Phuong Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Ho Chi Minh",
            "LocationCountry": "Vietnam",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Chien Vo Duc, MD.",
                  "LocationContactRole": "Contact",
                  "LocationContactEMail": "myhanhchien@gmail.com"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000008173",
            "ConditionMeshTerm": "Lung Diseases, Obstructive"
          },
          {
            "ConditionMeshId": "D000029424",
            "ConditionMeshTerm": "Pulmonary Disease, Chronic Obstructive"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10322",
            "ConditionBrowseLeafName": "Lung Diseases, Obstructive",
            "ConditionBrowseLeafAsFound": "Obstructive Pulmonary Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M22602",
            "ConditionBrowseLeafName": "Pulmonary Disease, Chronic Obstructive",
            "ConditionBrowseLeafAsFound": "Chronic Obstructive Pulmonary Disease",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          }
        ]
      }
    }
  }
}